K2 PRINCIPAL FUND, L.P. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 72 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
K2 PRINCIPAL FUND, L.P. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$442,000
-24.8%
58,772
+23.8%
0.05%0.0%
Q1 2022$588,000
-67.5%
47,462
-66.0%
0.05%
-66.0%
Q2 2021$1,808,000
+12.2%
139,499
+25.7%
0.15%
-50.8%
Q1 2020$1,611,000
-28.4%
111,0000.0%0.30%
+56.4%
Q4 2019$2,249,000
+4064.8%
111,000
+825.0%
0.20%
+4775.0%
Q4 2017$54,000
-76.6%
12,000
-67.5%
0.00%
-73.3%
Q3 2017$231,000
-45.4%
36,900
-81.7%
0.02%
-62.5%
Q4 2016$423,000201,5220.04%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders